Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Burzynski Clinic Presents Over Five Years Survival Data From Phase II Trials of ANP for Inoperable Brain Tumors at the Congress

11/15/2013 | 09:34pm US/Eastern

The Burzynski Clinic (BC) announced today that it made a keynote speaker presentation at the 2nd Annual Congress of Asia-Pacific Academy of Anti-Aging Medicine in Beijing, China. Based on the presentation in Beijing, a total of 401 eligible patients (patients who received over 28 days of treatment) with advanced inoperable brain tumors have been treated with antineoplaston A10 and antineoplastons AS2-1 therapy (ANP) in phase II studies. Most of the patients (87%) were diagnosed with high-grade tumors and the remaining patients were diagnosed with low-grade tumors. The patients were diagnosed by pathologists not associated with BC and objective responses were verified by Central Radiology Review. The group of 77 patients (19%) survived over five years from the treatment start. Of particular interest were results in patients with brainstem gliomas. The group of 17 patients with brainstem glioma underwent the treatment and 65% of these patients survived over five years. An additional group of 42 patients diagnosed with diffuse intrinsic pontine glioma (DIPG) have been treated and a total of 19% survived over five years.

The quality of survival is very good and there is no long-term toxicity related to ANP.

These clinical results are very encouraging, since they describe a positive ANP effect on some of the worst malignancies in the entire oncology field, but they will require FDA approval.

Burzynski Clinic is committed to developing treatments for cancer based on genomic and epigenomic principles.

Forward-looking statements in this release are made pursuant to the safe harbor provisions of the federal securities laws. Information contained in forward-looking statements is based on current expectations and is subject to change, and future events may differ materially from those discussed herein due to a number of factors, including, but not limited to, risks and uncertainties related to the clinic's ability to use Antineoplastons A10 and AS2-1. Burzynski Clinic does not undertake to update any such forward-looking statements or to publicly announce developments or events relating to the matters described herein.

For Burzynski Clinic
Carolyn Powers, 713-335-5664
carolyn@burzynskiclinic.com


© Business Wire 2013
Latest news
Date Title
<1m ago Manulife Investments receives approval for mutual fund mergers
<1m ago ADA : Wal-Mart Stores East Will Pay to $72,500 to Settle EEOC Disability Discrimination Lawsuit
<1m ago LORITO HOLDINGS S.A.R.L. AND ZEBRA HOLDINGS & INVESTMENTS S.A.R.L. : Acquire Subscription Receipts of Lundin Mining Corporation
2m ago PRICE & TIME : Deciphering the Short-Term USD Wiggles
3m ago PETROLEUM & RESOURCES : Nigerian lawmakers to probe Green Field Refineries contract
3m ago ALM : Community and corporate leaders partner to bring Power to the Magic City Classic
3m ago ALM : Volunteers set to clean Tallapoosa River October 22-25
3m ago RESEARCH AND MARKETS : India Laptop Market, Annual Tracker Report 2014
4m ago Fitch Releases Report on The Bank of New York Mellon Master Servicer
4m ago REXNORD CORPORATION : Conference Call to Report Second Quarter Fiscal Year 2015 Financial Results
Latest news
Advertisement
Hot News 
OIM : 16 october 2014 - PAYMENT OF DIVIDENDS SUSPENDED
CABELAS : Cabela’s® Announces Plans for Two New Stores
JAKKS PACIFIC : reg; Reports Improved Third Quarter Results for 2014
INFINERA : beats Street 3Q forecasts
FOXTONS : Downgrades Full-Year Earnings Guidance On Poor Third Quarter
Most Read News
1d ago ATMEL : Patent Issued for Apparatus and Method for Increasing the Quantity of Discrete Electronic Components in an Integrated Circuit Package
1d ago EXELON : ICC Approves ComEd’s Grand Prairie Gateway Project
1d ago TERADYNE : beats Street 3Q forecasts
1h ago Tesco accounting black hole deepens, chairman to step down
6h ago Unilever promises more cheap goods, cost cuts to tackle slowdown
Most recommended articles
2m ago PRICE & TIME : Deciphering the Short-Term USD Wiggles
7m ago Apple Pay creates powerful combination - MasterCard
23m ago Citigroup to revisit U.S. court over Argentine bond payments
33m ago Spirit Pub board rejects bid from cider maker C&C
36m agoDJSaint-Gobain Steps Up Cost-Cutting After 3Q Revenue Fall
Dynamic quotes  
ON
| OFF